These are due to extra-articular manifestation of RA itself, complication of Sjögren syndrome [3], and treatment with immunosuppressive agents including methotrexate (MTX) or tumor necrosis factor-α (TNF-α) blockers [4–9]. This evidence concerns the gene TNF and rheumatoid arthritis.